How Policy Surveillance Might Help to Counter the Opioid Epidemic
The astonishing number of opioid overdoses in the is attributable in part to the lack of legislation to curb over-prescription.
Pharmaceuticals
-
Read more: How Policy Surveillance Might Help to Counter the Opioid Epidemic -
Read more: How Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development? How Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development?
Moderna’s vaccine works using a completely novel mechanism, unlike any other vaccine currently approved anywhere in the world.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from July 2020.
-
Read more: COVID-19 Vaccine Advance Purchases Explained COVID-19 Vaccine Advance Purchases Explained
No vaccine for the novel coronavirus has been approved. Nevertheless, governments and organizations are making deals for tens of millions of doses.
-
Read more: First Do No Harm: The Independent Medicines and Medical Devices Safety Review First Do No Harm: The Independent Medicines and Medical Devices Safety Review
A new hard-hitting report on medicines and medical device safety presents controversial proposals that have the potential to improve NHS patient safety.
-
Read more: As Cities Decriminalize Psychedelics, Law Enforcement Should Step Back As Cities Decriminalize Psychedelics, Law Enforcement Should Step Back
Psychedelics may fill the growing need for innovative psychiatric drugs. Some cities, dissatisfied with the U.S. war on drugs, are decriminalizing them.
-
Read more: What Ever Happened to NIH’s “Fair Pricing” Clause? What Ever Happened to NIH’s “Fair Pricing” Clause?
It remains to be seen whether Congress or the Administration adopt more decisive measures toward the control of drug prices than they have in the past.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Topics include challenges with false negative tests for SARS-CoV-2 infection and difficulties in implementing and enforcing state opioid prescribing laws.
-
Read more: To Cut Prescription Drug Spending, Stop Delays for Generic Competition To Cut Prescription Drug Spending, Stop Delays for Generic Competition
While generic competition is crucial for reducing drug prices, brand-name drug manufacturers can utilize several strategies to delay such competition.
-
Read more: How Policies Enacted During COVID-19 Might Reduce Future Drug Spending How Policies Enacted During COVID-19 Might Reduce Future Drug Spending
A positive outcome of the pandemic may be the demonstration via emergency measures that state governments can be flexible in substitution policies.
